摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(1'-cyclohexenyl)-2-(p-methoxybenzyl)-1,3,4-trimethyl-1,2,5,6-tetrahydropyridine | 143950-96-3

中文名称
——
中文别名
——
英文名称
2-(1'-cyclohexenyl)-2-(p-methoxybenzyl)-1,3,4-trimethyl-1,2,5,6-tetrahydropyridine
英文别名
6-(cyclohexen-1-yl)-6-[(4-methoxyphenyl)methyl]-1,4,5-trimethyl-2,3-dihydropyridine
2-(1'-cyclohexenyl)-2-(p-methoxybenzyl)-1,3,4-trimethyl-1,2,5,6-tetrahydropyridine化学式
CAS
143950-96-3
化学式
C22H31NO
mdl
——
分子量
325.494
InChiKey
LTBQZWJGXBQMJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.15
  • 重原子数:
    24.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    12.47
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(1'-cyclohexenyl)-2-(p-methoxybenzyl)-1,3,4-trimethyl-1,2,5,6-tetrahydropyridine氢溴酸 作用下, 反应 21.0h, 以59%的产率得到2-(1'-cyclohexen)-yl-3,6,11α-trimethyl-8-hydroxy-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine
    参考文献:
    名称:
    Synthesis of C-2 substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines: binding studies on opioid receptors
    摘要:
    The racemic C-2 substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines 8a-k were prepared in three steps from the readily available 2-cyano-1,2,5,6-tetrahydropyridines 4a-c. This involved alkylation of the anion of 4a-c with the appropriate alkyl halide, displacement of thc cyano group in 5 or 6 by reaction with a Grignard reagent and cyclization under Grewe conditions (HBr, reflux). The equilibrium binding affinities of compounds 8a-k for the mu, delta and kappa-opioid receptor types were determined. Compounds 8c, 8e, 8j and 8k bearing a phenyl or olefinic substituent at C-2 display high kappa-receptor binding affinities demonstrating that the presence of a substituent at this position is important for kappa-receptor binding. The insensitivity of the binding of compounds 8j and 8k to sodium ions and guanine nucleotides at both mu and kappa-sites suggests that these 2-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines could behave as partial agonists or antagonists. The binding of the molecule 8e to mu and kappa sites was inhibited in the presence of these allosteric effectors, whereas N-methyl-2-phenyl-1,2,3,4,5.6-hexahydro-2,6-methano-3-benzazocine 8c appears to display the same kappa-agonist/mu-antagonist pharmacological profile as bremazocine 2.
    DOI:
    10.1016/0223-5234(92)90150-y
  • 作为产物:
    参考文献:
    名称:
    Synthesis of C-2 substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines: binding studies on opioid receptors
    摘要:
    The racemic C-2 substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines 8a-k were prepared in three steps from the readily available 2-cyano-1,2,5,6-tetrahydropyridines 4a-c. This involved alkylation of the anion of 4a-c with the appropriate alkyl halide, displacement of thc cyano group in 5 or 6 by reaction with a Grignard reagent and cyclization under Grewe conditions (HBr, reflux). The equilibrium binding affinities of compounds 8a-k for the mu, delta and kappa-opioid receptor types were determined. Compounds 8c, 8e, 8j and 8k bearing a phenyl or olefinic substituent at C-2 display high kappa-receptor binding affinities demonstrating that the presence of a substituent at this position is important for kappa-receptor binding. The insensitivity of the binding of compounds 8j and 8k to sodium ions and guanine nucleotides at both mu and kappa-sites suggests that these 2-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines could behave as partial agonists or antagonists. The binding of the molecule 8e to mu and kappa sites was inhibited in the presence of these allosteric effectors, whereas N-methyl-2-phenyl-1,2,3,4,5.6-hexahydro-2,6-methano-3-benzazocine 8c appears to display the same kappa-agonist/mu-antagonist pharmacological profile as bremazocine 2.
    DOI:
    10.1016/0223-5234(92)90150-y
点击查看最新优质反应信息

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯